DrugAug 16, 2023
Dofetilide Capsules 500 mcg (0.5mg), 60-count bottle recall — FDA D-1082-2023
Out of Specification result observed in content uniformity testing
Class IIIFDA: TerminatedSUN PHARMACEUTICAL INDUSTRIES Inc.
Latest records
Latest recalls — page 242
The newest recall records with useful source details are listed here.
VehicleAug 15, 2023
Sentra tie rod recall — NHTSA campaign 23V581000
Nissan North America, Inc. (Nissan) is recalling certain 2020-2022 Sentra vehicles. The left and/or right tie rod may bend.
tie rodNissan North America, Inc.
VehicleAug 15, 2023
Sorento labels recall — NHTSA campaign 23V579000
Kia America, Inc. (Kia) is recalling certain 2023 Sorento vehicles. The air bag warning labels on the driver and front passenger sun visors may detach. As such, these vehicles fail to…
labelsKia America, Inc.
VehicleAug 14, 2023
Jeep Compass instrument cluster/panel recall — NHTSA campaign 23V576000
Chrysler (FCA US, LLC) is recalling certain 2022-2023 Jeep Compass vehicles. The brightness level of the instrument panel cluster (IPC) may not be adjustable due to incorrect software in…
instrument cluster/panelChrysler (FCA US, LLC)
VehicleAug 14, 2023
Chrysler display function recall — NHTSA campaign 23V577000
Chrysler (FCA US, LLC) is recalling certain 2022-2023 Jeep Grand Cherokee, 2021-2023 Jeep Grand Cherokee L, and 2022-2024 Jeep Wagoneer and Grand Wagoneer vehicles. The Central Vision Park…
display functionChrysler (FCA US, LLC)
VehicleAug 10, 2023
Jeep Wrangler brake lights recall — NHTSA campaign 23V565000
Chrysler (FCA US, LLC) is recalling certain 2023 Jeep Wrangler vehicles. The spare tire may obstruct the view of the center high-mount brake light. As such, these vehicles fail to comply…
brake lightsChrysler (FCA US, LLC)
DrugAug 9, 2023
Central Admixture Pharmacy Services CARDIOPLEGIA SOLUTION, 7.5 mEq K, Reperfusate 4:1, low recall — FDA D-1023-2023
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
DrugAug 9, 2023
Central Admixture Pharmacy Services vancomycin 1.25 g/250 mL added to 0.9% Sodium Chloride recall — FDA D-0955-2023
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
DrugAug 9, 2023
Central Admixture Pharmacy Services CARDIOPLEGIA SOLUTION, 70 mEq K, Induction 8:1 recall — FDA D-1034-2023
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
DrugAug 9, 2023
Central Admixture Pharmacy Services CARDIOPLEGIA SOLUTION, 30 mEq K, Induction 4:1, High recall — FDA D-1017-2023
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
DrugAug 9, 2023
Central Admixture Pharmacy Services fentaNYL in 0.9% sodium chloride, 500 mcg/50 mL recall — FDA D-1054-2023
Lack of assurance of sterility: Lack of validation data for sanitization cycles
Class IIFDA: TerminatedCentral Admixture Pharmacy Services Inc.
DrugAug 9, 2023
Central Admixture Pharmacy Services Neonatal TPN Starter Bag, Amino Acids (trophamine) recall — FDA D-1014-2023
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
DrugAug 9, 2023
Central Admixture Pharmacy Services vancomycin 1.25 g/250 mL added to dextrose 5%, 5 mg/mL recall — FDA D-0950-2023
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
DrugAug 9, 2023
Central Admixture Pharmacy Services Neonatal TPN Starter Bag, Amino Acids (Trophamine) recall — FDA D-0996-2023
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
DrugAug 9, 2023
Central Admixture Pharmacy Services fentaNYL, 2500 mcg/50 mL, (50 mcg/mL), 50 mL Syringe recall — FDA D-1047-2023
Lack of assurance of sterility: Lack of validation data for sanitization cycles
Class IIFDA: TerminatedCentral Admixture Pharmacy Services Inc.
DrugAug 9, 2023
Central Admixture Pharmacy Services oxyTOCIN 10 units added to Lactated Ringer's 500 mL, IV recall — FDA D-0972-2023
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
DrugAug 9, 2023
Central Admixture Pharmacy Services oxyTOCIN 15 units added to Lactated Ringer's 250 mL, IV recall — FDA D-0975-2023
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
DrugAug 9, 2023
Central Admixture Pharmacy Services Cardioplegia Solution del Nido Formula, IV Bag, Total recall — FDA D-0956-2023
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
DrugAug 9, 2023
Central Admixture Pharmacy Services TRANSPLANT SOLUTION, Plasma-Lyte A - 75 ml, MSA/MSG 0.92 recall — FDA D-1026-2023
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
DrugAug 9, 2023
Central Admixture Pharmacy Services oxyTOCIN 30 units added to 0.9% sodium chloride 500 mL recall — FDA D-0986-2023
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
DrugAug 9, 2023
Central Admixture Pharmacy Services vancomycin 2 g/500 mL added to 0.9% Sodium Chloride, 4 recall — FDA D-0970-2023
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
DrugAug 9, 2023
Central Admixture Pharmacy Services Neonatal TPN Starter Bag, Amino Acids (trophamine) recall — FDA D-1010-2023
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
DrugAug 9, 2023
Central Admixture Pharmacy Services Neonatal TPN Starter Bag, Amino Acids (trophamine) recall — FDA D-0993-2023
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
DrugAug 9, 2023
Central Admixture Pharmacy Services Neonatal TPN Starter Bag, Amino Acids (Trophamine) recall — FDA D-0994-2023
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class IIFDA: TerminatedCentral Admixture Pharmacy Services, Inc.
Browse by month
Recent recall archives
Browse recent months with enough recall history for useful comparison.
August 2026149 records · 4 categoriesJuly 2026371 records · 4 categoriesJune 2026375 records · 4 categoriesMay 2026340 records · 4 categoriesApril 2026415 records · 4 categoriesMarch 2026190 records · 4 categoriesFebruary 2026331 records · 4 categoriesJanuary 2026212 records · 4 categoriesDecember 2025389 records · 4 categoriesNovember 2025326 records · 4 categoriesOctober 2025455 records · 4 categoriesSeptember 2025180 records · 4 categories